Chad Therapeutics Inc.’s 3rd-Quarter Profit Soars

Chad Therapeutics Inc., a Chatsworth company that makes devices that conserve oxygen in tanks used by patients with respiratory problems, reported that its fiscal third-quarter earnings surged to $163,530 from $45,563 a year earlier. Chad’s revenue for the quarter that ended Dec. 31 totaled $868,219, up 87% from revenue of $463,151 in fiscal 1991’s third quarter.

In the latest nine-month period, Chad earned $465,587, while its revenue nearly doubled to $2.42 million. A year earlier, the company lost $200,755 on $1.25 million in revenue.